Cipesta DS®

Cipesta DS®

Therapeutic Segment: Antibiotic

Generic Name: Ciprofloxacin

Indication:

In adults with:

  • Lower respiratory tract infections due to Gram-negative bacteria: exacerbations of chronic obstructive pulmonary disease, broncho-pulmonary infections in cystic fibrosis or in bronchiectasis, pneumonia.
  •  Chronic suppurative otitis media.
  • Acute exacerbation of chronic sinusitis especially if these are caused by Gram-negative bacteria
  •  Urinary tract infections
  •  Genital tract infections: gonococcal uretritis and cervicitis due to susceptible Neisseria gonorrhoeae, epididymo-orchitis including cases due to susceptible Neisseria gonorrhoeae and pelvic inflammatory disease including cases due to susceptible Neisseria gonorrhoeae.
  •  Infections of the gastro intestinal tract (e.g. travellers’ diarrhea)
  •  Intra-abdominal infections
  •  Infections of the skin and soft tissue caused by Gram-negative bacteria
  •  Malignant external otitis
  •  Infections of the bones and joints
  •  Prophylaxis of invasive infections due to Neisseria meningitidis
  •  Inhalation anthrax (post-exposure prophylaxis and curative treatment)
  •  Typhoid fever caused by Salmonella typhi.
    May be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection.

Indicated in children and adolescents with:

  • Broncho-pulmonary i nfections in cystic fibrosis caused by Pseudomonas aeruginosa
  • Complicated urinary tract infections and pyelonephritis
  • Inhalation anthrax (post-exposure prophylaxis and curative treatment)

Available as:

Injectables
  • 4mg/ml